1. Home
  2. GEOS vs PYXS Comparison

GEOS vs PYXS Comparison

Compare GEOS & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • PYXS
  • Stock Information
  • Founded
  • GEOS 1980
  • PYXS 2018
  • Country
  • GEOS United States
  • PYXS United States
  • Employees
  • GEOS N/A
  • PYXS N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • PYXS Health Care
  • Exchange
  • GEOS Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • GEOS 72.9M
  • PYXS 79.4M
  • IPO Year
  • GEOS 1997
  • PYXS 2021
  • Fundamental
  • Price
  • GEOS $16.29
  • PYXS $1.82
  • Analyst Decision
  • GEOS
  • PYXS Strong Buy
  • Analyst Count
  • GEOS 0
  • PYXS 5
  • Target Price
  • GEOS N/A
  • PYXS $7.75
  • AVG Volume (30 Days)
  • GEOS 192.8K
  • PYXS 798.6K
  • Earning Date
  • GEOS 08-07-2025
  • PYXS 11-11-2025
  • Dividend Yield
  • GEOS N/A
  • PYXS N/A
  • EPS Growth
  • GEOS N/A
  • PYXS N/A
  • EPS
  • GEOS N/A
  • PYXS N/A
  • Revenue
  • GEOS $115,527,000.00
  • PYXS $2,820,000.00
  • Revenue This Year
  • GEOS N/A
  • PYXS N/A
  • Revenue Next Year
  • GEOS N/A
  • PYXS N/A
  • P/E Ratio
  • GEOS N/A
  • PYXS N/A
  • Revenue Growth
  • GEOS N/A
  • PYXS N/A
  • 52 Week Low
  • GEOS $5.51
  • PYXS $0.83
  • 52 Week High
  • GEOS $21.60
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 46.07
  • PYXS 69.41
  • Support Level
  • GEOS $15.37
  • PYXS $1.75
  • Resistance Level
  • GEOS $17.29
  • PYXS $2.00
  • Average True Range (ATR)
  • GEOS 1.39
  • PYXS 0.16
  • MACD
  • GEOS -0.49
  • PYXS 0.04
  • Stochastic Oscillator
  • GEOS 14.77
  • PYXS 75.34

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: